401003 Sigma-Aldrich(±)-Ibuprofen - CAS 15687-27-1 - Calbiochem
A nonsteroidal anti-inflammatory drug (NSAID) that acts as a reversible and competitive inhibitor of cyclooxygenase 1 (COX-1) (IC₅₀ = 4.85 µM).
More>> A nonsteroidal anti-inflammatory drug (NSAID) that acts as a reversible and competitive inhibitor of cyclooxygenase 1 (COX-1) (IC₅₀ = 4.85 µM). Less<<Synonymes: [(±)-2-(4-Isobutylphenyl)-propionic Acid
Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| CAS # | Empirical Formula |
|---|---|
| 15687-27-1 | C₁₃H₁₈O₂ |
Prix & Disponibilité
| Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
|---|---|---|---|---|---|---|
| 401003-1GM |
|
Ampoule plast. | 1 gm |
|
— |
| Product Information | |
|---|---|
| CAS number | 15687-27-1 |
| ATP Competitive | Y |
| Form | White solid |
| Hill Formula | C₁₃H₁₈O₂ |
| Chemical formula | C₁₃H₁₈O₂ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | COX-1 |
| Primary Target IC<sub>50</sub> | 4.85 µM against COX-1 |
| Purity | ≥98% by titration |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | MU6640000 |
| Safety Information | |
|---|---|
| R Phrase | R: 22 Harmful if swallowed. |
| S Phrase | S: 36 Wear suitable protective clothing. |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 401003-1GM | 04055977189377 |
Documentation
(±)-Ibuprofen - CAS 15687-27-1 - Calbiochem FDS
| Titre |
|---|
(±)-Ibuprofen - CAS 15687-27-1 - Calbiochem Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 401003 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Asanuma, M., et al. 2001. J. Neurochem. 76, 1895. Blasko, I., et al. 2001. Neurobiol. Dis. 8, 1094. Ouellet, M., et al. 2001. Proc. Natl. Acad. Sci. USA 98, 14583. Casper, D., et al. 2000. Neurosci. Lett. 289, 201. Lambat, Z., et al. 2000. Metab. Brain Dis. 15, 249. Lim, G.P., et al. 2000. J. Neurosci. 20, 5709. Ogawa, O., et al. 2000. Eur. J. Pharmacol. 408, 137. Wyss-Coray, T., and Mucke, L. 2000. Nat. Med. 6, 973. Lehmann, J.M., et al. 1997. J. Biol. Chem. 272, 3406. Boneburg, E.M., et al. 1996. J. Clin. Pharmacol. 36, 16S. Mitchell, J.A., et al. 1994. Proc. Natl. Acad. Sci. USA 90, 11693. |



